T. Rowe Price Associates’s Universal Health Services UHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7M Sell
87,630
-14,419
-14% -$2.96M ﹤0.01% 1106
2025
Q4
$22.3M Sell
102,049
-8,725
-8% -$1.93M ﹤0.01% 1047
2025
Q3
$22.6M Sell
110,774
-297,784
-73% -$53.6M ﹤0.01% 1033
2025
Q2
$74M Buy
408,558
+324,550
+386% +$58.6M 0.01% 633
2025
Q1
$15.8M Buy
84,008
+625
+0.7% +$114K ﹤0.01% 1006
2024
Q4
$15M Sell
83,383
-7,578
-8% -$1.54M ﹤0.01% 1051
2024
Q3
$20.8M Sell
90,961
-3,484
-4% -$751K ﹤0.01% 983
2024
Q2
$17.5M Buy
94,445
+2,230
+2% +$395K ﹤0.01% 987
2024
Q1
$16.8M Sell
92,215
-1,234
-1% -$204K ﹤0.01% 1020
2023
Q4
$14.2M Buy
93,449
+3,031
+3% +$408K ﹤0.01% 1029
2023
Q3
$11.4M Sell
90,418
-2,808
-3% -$383K ﹤0.01% 1054
2023
Q2
$14.7M Sell
93,226
-1,214
-1% -$169K ﹤0.01% 1012
2023
Q1
$12M Sell
94,440
-153
-0.2% -$21.1K ﹤0.01% 1023
2022
Q4
$13.3M Sell
94,593
-2,620
-3% -$309K ﹤0.01% 1003
2022
Q3
$8.57M Sell
97,213
-17
-0% -$1.76K ﹤0.01% 1093
2022
Q2
$9.79M Sell
97,230
-9,608
-9% -$1.2M ﹤0.01% 1321
2022
Q1
$15.5M Sell
106,838
-10,136
-9% -$1.4M ﹤0.01% 1297
2021
Q4
$15.2M Sell
116,974
-18,686
-14% -$2.4M ﹤0.01% 1338
2021
Q3
$18.8M Sell
135,660
-2,197
-2% -$333K ﹤0.01% 1313
2021
Q2
$20.2M Sell
137,857
-3,640
-3% -$550K ﹤0.01% 1296
2021
Q1
$18.9M Sell
141,497
-54,839
-28% -$7.27M ﹤0.01% 1289
2020
Q4
$27M Sell
196,336
-5,756
-3% -$716K ﹤0.01% 1140
2020
Q3
$21.6M Sell
202,092
-10,028
-5% -$1.07M ﹤0.01% 1140
2020
Q2
$19.7M Sell
212,120
-49,536
-19% -$4.95M ﹤0.01% 1151
2020
Q1
$25.9M Buy
261,656
+14,370
+6% +$1.82M ﹤0.01% 990
2019
Q4
$35.5M Sell
247,286
-6,966
-3% -$993K ﹤0.01% 1018
2019
Q3
$37.8M Sell
254,252
-127,749
-33% -$18.3M 0.01% 959
2019
Q2
$49.8M Sell
382,001
-113,299
-23% -$14.3M 0.01% 898
2019
Q1
$66.3M Buy
495,300
+12,693
+3% +$1.67M 0.01% 765
2018
Q4
$56.3M Sell
482,607
-202,543
-30% -$25.5M 0.01% 779
2018
Q3
$87.6M Sell
685,150
-59,910
-8% -$7.35M 0.01% 712
2018
Q2
$83M Sell
745,060
-127,093
-15% -$14.9M 0.01% 716
2018
Q1
$103M Sell
872,153
-158,876
-15% -$18.9M 0.02% 637
2017
Q4
$117M Sell
1,031,029
-244,658
-19% -$26.1M 0.02% 589
2017
Q3
$142M Buy
1,275,687
+51,612
+4% +$5.81M 0.02% 520
2017
Q2
$149M Sell
1,224,075
-145,633
-11% -$17.3M 0.03% 503
2017
Q1
$170M Sell
1,369,708
-109,747
-7% -$13M 0.03% 463
2016
Q4
$157M Sell
1,479,455
-1,399,281
-49% -$166M 0.03% 475
2016
Q3
$355M Sell
2,878,736
-875,449
-23% -$111M 0.07% 281
2016
Q2
$503M Sell
3,754,185
-45,649
-1% -$6.02M 0.11% 218
2016
Q1
$474M Buy
3,799,834
+381,683
+11% +$42.9M 0.1% 231
2015
Q4
$408M Buy
3,418,151
+31,667
+0.9% +$3.87M 0.09% 252
2015
Q3
$423M Sell
3,386,484
-41,489
-1% -$5.77M 0.09% 242
2015
Q2
$487M Sell
3,427,973
-1,675,750
-33% -$210M 0.1% 230
2015
Q1
$601M Sell
5,103,723
-98,416
-2% -$10.9M 0.12% 197
2014
Q4
$579M Buy
5,202,139
+165,836
+3% +$17.4M 0.12% 203
2014
Q3
$526M Buy
5,036,303
+160,922
+3% +$17.1M 0.11% 205
2014
Q2
$467M Sell
4,875,381
-33,940
-0.7% -$2.93M 0.1% 236
2014
Q1
$403M Sell
4,909,321
-13,833
-0.3% -$1.11M 0.09% 262
2013
Q4
$400M Sell
4,923,154
-580,100
-11% -$46.3M 0.09% 262
2013
Q3
$413M Buy
5,503,254
+5,200
+0.1% +$363K 0.1% 243
2013
Q2
$368M Buy
+5,498,054
New +$363M 0.1% 258

Other funds holding UHS

T. Rowe Price Associates's UHS Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Universal Health Services (UHS) stake by 14% in Q1 2026, selling an estimated $2.96M and leaving 87,630 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1106.

T. Rowe Price Associates first reported a position in UHS in Q2 2013 and has held it in 52 quarters since. The position peaked at $601M in Q1 2015. 651 funds tracked by Wall St. Rank hold UHS as of Q1 2026.

  • T. Rowe Price Associates held 87,630 shares of Universal Health Services worth $15.7M as of Q1 2026.
  • T. Rowe Price Associates sold 14,419 Universal Health Services shares in Q1 2026, an estimated $2.96M.
  • Universal Health Services made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1106 holding.
  • T. Rowe Price Associates first reported a position in Universal Health Services in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Universal Health Services position peaked at $601M in Q1 2015.
  • 651 funds tracked by Wall St. Rank held Universal Health Services as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.